McGeorge Anne
SEC insider (Form 3/4/5 filer). CIK 0001779934. Director at Dianthus Therapeutics, Inc. /DE/ (DNTH) and 1 other issuer. 13 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in NEW YORK, NY.
Companies McGeorge Anne has filed insider reports for
- Dianthus Therapeutics, Inc. /DE/ (DNTH): Director
- Oncology Institute, Inc. (TOI): Director
McGeorge Anne
CIK: 0001779934
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect1K shares at avg. $110.64$111K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect1.8K shares at avg. $109.30$197K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect700 shares at avg. $111.41$78K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect1.3K shares at avg. $19.36$24K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
ExerciseDirect6.5K shares at avg. $11.20$73K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect1.5K shares at avg. $107.58$156K - Aug 10, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
SaleDirect2.8K shares at avg. $108.38$303K - Jul 27, 2026TOI
Oncology Institute, Inc.
AwardDirect41.2K shares- - May 21, 2026DNTH
Dianthus Therapeutics, Inc. /DE/
AwardDirectStock Option (Right to Buy)
6.1K shares- - Nov 20, 2025TOI
Oncology Institute, Inc.
AwardDirect67.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 |  DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 1,000 | $110.64 | $110,640 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 1,800 | $109.30 | $196,740 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 700 | $111.41 | $77,987 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 1,250 | $19.36 | $24,200 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Exercise | 6,500 | $11.20 | $72,800 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 1,450 | $107.58 | $155,991 | Direct |
| Aug 10, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Sale | 2,800 | $108.38 | $303,464 | Direct |
| Jul 27, 2026 |  TOI Oncology Institute, Inc. | Award | 41,165 | - | $0 | Direct |
| May 21, 2026 | DNTH Dianthus Therapeutics, Inc. /DE/ | Award Stock Option (Right to Buy) | 6,090 | - | - | Direct |
| Nov 20, 2025 | TOI Oncology Institute, Inc. | Award | 67,901 | - | - | Direct |
1-10 of 13 transactions